SPY337.44+4.64 1.39%
DIA280.04+2.85 1.03%
IXIC11,012.24+229.42 2.13%

Biocryst Pharmaceuticals Q3 EPS $(0.34) Down From $(0.28) YoY, Sales $1.8M Up From $1.454M YoY

Biocryst Pharmaceuticals (NASDAQ:BCRX) reported quarterly losses of $(0.34) per share. This is a 21.43 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $1.8 million

Benzinga · -

Biocryst Pharmaceuticals (NASDAQ:BCRX) reported quarterly losses of $(0.34) per share. This is a 21.43 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $1.8 million in sales this quarter. This is a 23.80 percent increase over sales of $1.454 million the same period last year.